Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:40993492

SSBP1 is a prognostic biomarker and promotes the progression of lung adenocarcinoma via p53 signaling pathway.

Discover oncology · 2025 doi:10.1007/s12672-025-03716-4

Paper

partial

Experiment

partial

Data

partial

Analysis

absent

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:40993492
kind
science-record
content_hash
sha256:762089cbf67875fd5a7499b697451ec2f487bc10e80b10804e830930402deeed
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T10:25:53Z
updated_at
2026-11-01T10:25:53Z
generator object · 3 fields
name
corpus-assay-engine
converter
sep_to_sci_v1
source_package_schema
urn:bntrg:sep:1.0.0
paper object · 10 fields
state
partial
title
SSBP1 is a prognostic biomarker and promotes the progression of lung adenocarcinoma via p53 signaling pathway.
doi
10.1007/s12672-025-03716-4
pmid
40993492
authors
null
journal
Discover oncology
year
2025
abstract
null
claims array · 1 item
[0] object · 6 fields
id
claim-1
statement
the headline numerical result the paper states for its main finding
kind
qualitative
state
blocked
target object · 4 fields
value
null
unit
null
tolerance
null
source
null
evidence array · 0 items
gaps array · 2 items
[0]
abstract
[1]
authors
experiment object · 8 fields
state
partial
objective
the headline numerical result the paper states for its main finding
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate and its interval from the source
kind
other
state
complete
blocked_on
null
description
The number a replication must land on, and the sentence it came from.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:40993492
outputs array · 1 item
[0]
the published estimate, its unit and its interval
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data behind the published result
kind
data-preparation
state
blocked
blocked_on
data:not_downloaded
description
The published result cannot be recomputed without the data the paper analysed.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the analysis programme
kind
analysis
state
blocked
blocked_on
no owned computational capability is bound to this experiment
description
Re-run the paper's analysis on the source data and produce the registered result. | SEP input not carried into the asset list: materials:the source data behind the published result in pmid:40993492
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the registered result
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 3 items
[0]
step:obtain_source_data blocked on data:not_downloaded
[1]
step:run_analysis blocked on no owned computational capability is bound to this experiment
[2]
step:run_analysis input 'materials:the source data behind the published result in pmid:40993492' does not resolve to a declared asset
data object · 3 fields
state
partial
assets array · 1 item
[0] object · 15 fields
id
source:pmid:40993492
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1007/s12672-025-03716-4
sha256
sha256:b1bdd23d031b7aaa9bfe7990f95878e035445d77e8ee8bd73dea4760492d8184
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1007/s12672-025-03716-4
version
null
note
Source read by the package builder: full_text.
structure object · 1 field
access_state
full_text
gaps array · 1 item
[0]
asset:source:pmid:40993492 not verified
analysis object · 4 fields
state
absent
methods array · 0 items
targets array · 0 items
gaps array · 2 items
[0]
method
[1]
targets
capability object · 3 fields
state
absent
requirements array · 0 items
gaps array · 1 item
[0]
capability
readiness object · 8 fields
state
partial
tier
null
blocked_on
null
axes object · 0 fields
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 1 item
[0]
source:pmid:40993492
steps array · 1 item
[0]
read_published_estimate
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 1 item
[0]
xml
capabilities array · 0 items
data_gaps array · 1 item
[0]
source:pmid:40993492
gaps array · 1 item
[0]
corpus_record_absent
review object · 5 fields
state
partial
machine_critique object · 7 fields
status
blocked
providers array · 1 item
[0] object · 7 fields
provider
minimax_alt
model
MiniMax-M3
prompt_version
full-text-reading-v1
prompt_hash
fa318edeea1f855db871580d4763c71d47ad402f51062f822fb2fb1143b90c7c
source_hash
b1bdd23d031b7aaa9bfe7990f95878e035445d77e8ee8bd73dea4760492d8184
raw_response_sha256
sha256:8e910ab114bb4774691fe60fcc09b93a8ebcaa0f423a83f7837dc3c7b1a65e8e
raw_response_chars
62628
target_providers array · 0 items
agreement
false
disagreements array · 0 items
agreement_basis object · 2 fields
policy
decisive_fields
decisive_fields array · 4 items
[0]
work_type
[1]
number_stated
[2]
parent_value
[3]
unit
blinded
true
human_critique object · 5 fields
status
not_run
reviewer
null
signed_at
null
conflict_checked
false
commentary
null
stages array · 7 items
[0] object · 4 fields
key
target_materials
status
pending
reason
null
evidence
null
[1] object · 4 fields
key
independent_readings
status
blocked
reason
The independent readings are incomplete or disagree; the source evidence must resolve the difference.
evidence object · 1 field
provider_errors array · 3 items
[0] object · 4 fields
provider
minimax
model
MiniMax-M3.1-Flash
reason
a quoted statement is absent from the supplied text
raw_response
{"target_result":"SSBP1 was significantly overexpressed in LUAD tissues and elevated SSBP1 expression was associated with worse OS, DSS, and PFI; the supplied text does not state a numerical effect size for this headline result.","work_type":"analysis_plus_physical_validation","physical_methods":["RNA interference knockdown of SSBP1 in A549 and H1299 LUAD cell lines","Cell proliferation assay","Cell migration and metastasis assays","Cell-cycle and p53-signaling pathway expression analysis","Western blot","qRT-PCR","Immunohistochemistry"],"analysis_methods":["Wilcoxon rank-sum test","Signed-rank test","Benjamini-Hochberg false-discovery-rate correction","Kaplan-Meier survival analysis","Log-rank test","Univariate Cox proportional hazards regression","Multivariate Cox proportional hazards regression","Receiver operating characteristic curve analysis","Area under the ROC curve","KEGG pathway enrichment analysis","Hierarchical clustering","Single-cell RNA-sequencing analysis","Student's t-test","Two-way ANOVA"],"statistical_method":"Non-parametric Wilcoxon rank-sum tests, with signed-rank tests for paired data when useful, were used to test SSBP1 differential expression between tumor and normal tissues; the Benjamini-Hochberg approach was used to control the false discovery rate.","method_evidence":"To assess the SSBP1 differential expression between tumor and normal tissues in different types of cancer, we used non-parametric statistical tests. These included Wilcoxon rank-sum tests to compare the levels of expression in tumor and normal tissues, and signed-rank tests to take paired data into consideration when useful. The Benjamini-Hochberg approach was used to control the false discovery rate (FDR) and further adjust statistical significance for multiple comparisons.","repositories":[{"repository":"UCSC Xena database","accession":"https://xenabrowser.net/datapages/","data_description":"Normalized RNA-sequencing results from multiple cancer types in TCGA, together with SSBP1 expression data and clinical variables including OS, DSS, tumor stage, age, gender, treatment history, and tumor type.","evidence":"The data for the pan-cancer expression profiles came from the UCSC Xena database, which contains normalized RNA sequencing (RNA-Seq) results from many different cancer types found in The Cancer Genome Atlas (TCGA) (https://xenabrowser.net/datapages/). For each kind of tumor that was accessible, we extracted the SSBP1 expression data and associated clinical variables, including OS, DSS, tumor stage, age, gender, treatment history, and tumor type.","publicly_downloadable":false},{"repository":"The Cancer Genome Atlas","accession":"unknown","data_description":"Tumor and normal-tissue expression data used to compare SSBP1 expression in LUAD and other cancers; the pan-cancer analysis also used associated survival and clinical variables.","evidence":"The data for the pan-cancer expression profiles came from the UCSC Xena database, which contains normalized RNA sequencing (RNA-Seq) results from many different cancer types found in The Cancer Genome Atlas (TCGA) (https://xenabrowser.net/datapages/).","publicly_downloadable":false},{"repository":"GTEx","accession":"unknown","data_description":"Dataset used with TCGA and the GSE datasets to compare SSBP1 expression in LUAD tumor tissues and normal lung tissues; its exact accession and detailed contents are not stated.","evidence":"In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.","publicly_downloadable":false},{"repository":"GSE19188","accession":"GSE19188","data_description":"Dataset used in the LUAD expression analysis alongside TCGA, GTEx, and GSE63459; the source does not specify its detailed contents or an explicit download statement.","evidence":"In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.","publicly_downloadable":false},{"repository":"GSE63459","accession":"GSE63459","data_description":"Dataset used in the LUAD expression analysis alongside TCGA, GTEx, and GSE19188; the source does not specify its detailed contents or an explicit download statement.","evidence":"In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.","publicly_downloadable":false}],"availability_statement":"The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.","data_on_request":true,"source_claims":["SSBP1, a mitochondrial single-strand binding protein, was found to be significantly overexpressed in lung adenocarcinoma (LUAD) tissues, indicating its potential as a diagnostic biomarker.","In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.","Moreover, high SSBP1 expression was strongly associated with worse overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI), further supporting its role as a prognostic marker.","Multivariate Cox regression analysis confirmed that SSBP1 remains an independent predictor of poor prognosis in LUAD patients.","Functional studies showed that knockdown of SSBP1 in LUAD cell lines (A549 and H1299) led to significantly reduced proliferation and migration, coupled with downregulation of key cell cycle regulators such as CDK4 and CDK6.","Additionally, SSBP1 silencing inhibited LUAD cell metastasis through the p53 signaling pathway, affecting the expression of EMT markers like N-cadherin and E-cadherin.","The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request."],"missing_information":["The supplied source does not state a numerical effect size, confidence interval, hazard ratio, or p-value for the headline LUAD overexpression result.","No accession is printed for TCGA, GTEx, or UCSC Xena beyond the printed Xena URL.","The text does not explicitly state that the UCSC Xena, TCGA, GTEx, GSE19188, or GSE63459 data can be downloaded without an application, embargo, or request.","The individual data contents of GTEx, GSE19188, and GSE63459 are not separately specified.","The paper's prognostic-analysis section discusses hepatocellular carcinoma rather than explicitly stating which survival method was applied specifically to the LUAD headline result."],"evidence_spans":["SSBP1, a mitochondrial single-strand binding protein, was found to be significantly overexpressed in lung adenocarcinoma (LUAD) tissues, indicating its potential as a diagnostic biomarker.","In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.","Moreover, high SSBP1 expression was strongly associated with worse overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI), further supporting its role as a prognostic marker.","Multivariate Cox regression analysis confirmed that SSBP1 remains an independent predictor of poor prognosis in LUAD patients.","To assess the SSBP1 differential expression between tumor and normal tissues in different types of cancer, we used non-parametric statistical tests. These included Wilcoxon rank-sum tests to compare the levels of expression in tumor and normal tissues, and signed-rank tests to take paired data into consideration when useful.","The Benjamini-Hochberg approach was used to control the false discovery rate (FDR) and further adjust statistical significance for multiple comparisons.","The data for the pan-cancer expression profiles came from the UCSC Xena database, which contains normalized RNA sequencing (RNA-Seq) results from many different cancer types found in The Cancer Genome Atlas (TCGA) (https://xenabrowser.net/datapages/).","For each kind of tumor that was accessible, we extracted the SSBP1 expression data and associated clinical variables, including OS, DSS, tumor stage, age, gender, treatment history, and tumor type.","Functional studies showed that knockdown of SSBP1 in LUAD cell lines (A549 and H1299) led to significantly reduced proliferation and migration, coupled with downregulation of key cell cycle regulators such as CDK4 and CDK6.","The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request."]}
[1] object · 4 fields
provider
minimax
model
null
reason
HTTP Error 429: Too Many Requests
raw_response
null
[2] object · 4 fields
provider
minimax_alt
model
null
reason
HTTP Error 429: Too Many Requests
raw_response
null
[2] object · 4 fields
key
source_resolution
status
pending
reason
null
evidence
null
[3] object · 4 fields
key
protocol_reconstruction
status
pending
reason
null
evidence
null
[4] object · 4 fields
key
control_execution
status
pending
reason
null
evidence
null
[5] object · 4 fields
key
control_comparison
status
pending
reason
null
evidence
null
[6] object · 4 fields
key
publication
status
pending
reason
null
evidence
null
gaps array · 2 items
[0]
review.human_critique
[1]
review.machine_critique.blocked
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 1 item
[0] object · 3 fields
id
package:fb5397ae07cf3dd2365f450608b0c07375a4baf603bc91ce59bde9aaac77038e
type
sep_package
label
SEP v1 package for pmid:40993492
activities array · 1 item
[0] object · 4 fields
id
activity:conversion:pmid:40993492
type
conversion
used array · 1 item
[0]
package:fb5397ae07cf3dd2365f450608b0c07375a4baf603bc91ce59bde9aaac77038e
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:minimax_alt
type
model
label
minimax_alt
[1] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
source_run_id
run-20261023T122449232913
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
4a0ea985-8c7b-404a-b4ac-8262608b4374
parent_hash
fb5397ae07cf3dd2365f450608b0c07375a4baf603bc91ce59bde9aaac77038e
fork_of
null
gaps array · 13 items
[0]
abstract
[1]
asset:source:pmid:40993492 not verified
[2]
authors
[3]
capability
[4]
corpus_record_absent
[5]
execution.not_run
[6]
method
[7]
review.human_critique
[8]
review.machine_critique.blocked
[9]
step:obtain_source_data blocked on data:not_downloaded
[10]
step:run_analysis blocked on no owned computational capability is bound to this experiment
[11]
step:run_analysis input 'materials:the source data behind the published result in pmid:40993492' does not resolve to a declared asset
[12]
targets
Complete file
{"sci_version": "1.0", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:40993492", "kind": "science-record", "revision": 1, "content_hash": "sha256:762089cbf67875fd5a7499b697451ec2f487bc10e80b10804e830930402deeed", "created_at": "2026-11-01T10:25:53Z", "updated_at": "2026-11-01T10:25:53Z", "generator": {"name": "corpus-assay-engine", "converter": "sep_to_sci_v1", "source_package_schema": "urn:bntrg:sep:1.0.0"}, "paper": {"state": "partial", "title": "SSBP1 is a prognostic biomarker and promotes the progression of lung adenocarcinoma via p53 signaling pathway.", "doi": "10.1007/s12672-025-03716-4", "pmid": "40993492", "authors": null, "journal": "Discover oncology", "year": 2025, "abstract": null, "claims": [{"id": "claim-1", "statement": "the headline numerical result the paper states for its main finding", "kind": "qualitative", "state": "blocked", "target": {"value": null, "unit": null, "tolerance": null, "source": null}, "evidence": []}], "gaps": ["abstract", "authors"]}, "experiment": {"state": "partial", "objective": "the headline numerical result the paper states for its main finding", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate and its interval from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The number a replication must land on, and the sentence it came from.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:40993492"], "outputs": ["the published estimate, its unit and its interval"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data behind the published result", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:not_downloaded", "description": "The published result cannot be recomputed without the data the paper analysed.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the analysis programme", "kind": "analysis", "state": "blocked", "blocked_on": "no owned computational capability is bound to this experiment", "description": "Re-run the paper's analysis on the source data and produce the registered result. | SEP input not carried into the asset list: materials:the source data behind the published result in pmid:40993492", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the registered result"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:not_downloaded", "step:run_analysis blocked on no owned computational capability is bound to this experiment", "step:run_analysis input 'materials:the source data behind the published result in pmid:40993492' does not resolve to a declared asset"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:40993492", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1007/s12672-025-03716-4", "sha256": "sha256:b1bdd23d031b7aaa9bfe7990f95878e035445d77e8ee8bd73dea4760492d8184", "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1007/s12672-025-03716-4", "version": null, "note": "Source read by the package builder: full_text.", "structure": {"access_state": "full_text"}}], "gaps": ["asset:source:pmid:40993492 not verified"]}, "analysis": {"state": "absent", "methods": [], "targets": [], "gaps": ["method", "targets"]}, "capability": {"state": "absent", "requirements": [], "gaps": ["capability"]}, "readiness": {"state": "partial", "tier": null, "blocking_axis": null, "blocked_on": null, "axes": {}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:40993492"], "steps": ["read_published_estimate"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": ["xml"], "capabilities": [], "data_gaps": ["source:pmid:40993492"]}, "gaps": ["corpus_record_absent"]}, "review": {"state": "partial", "machine_critique": {"status": "blocked", "providers": [{"provider": "minimax_alt", "model": "MiniMax-M3", "prompt_version": "full-text-reading-v1", "prompt_hash": "fa318edeea1f855db871580d4763c71d47ad402f51062f822fb2fb1143b90c7c", "source_hash": "b1bdd23d031b7aaa9bfe7990f95878e035445d77e8ee8bd73dea4760492d8184", "raw_response_sha256": "sha256:8e910ab114bb4774691fe60fcc09b93a8ebcaa0f423a83f7837dc3c7b1a65e8e", "raw_response_chars": 62628}], "target_providers": [], "agreement": false, "disagreements": [], "agreement_basis": {"policy": "decisive_fields", "decisive_fields": ["work_type", "number_stated", "parent_value", "unit"]}, "blinded": true}, "human_critique": {"status": "not_run", "reviewer": null, "signed_at": null, "conflict_checked": false, "commentary": null}, "stages": [{"key": "target_materials", "status": "pending", "reason": null, "evidence": null}, {"key": "independent_readings", "status": "blocked", "reason": "The independent readings are incomplete or disagree; the source evidence must resolve the difference.", "evidence": {"provider_errors": [{"provider": "minimax", "model": "MiniMax-M3.1-Flash", "reason": "a quoted statement is absent from the supplied text", "raw_response": "{\"target_result\":\"SSBP1 was significantly overexpressed in LUAD tissues and elevated SSBP1 expression was associated with worse OS, DSS, and PFI; the supplied text does not state a numerical effect size for this headline result.\",\"work_type\":\"analysis_plus_physical_validation\",\"physical_methods\":[\"RNA interference knockdown of SSBP1 in A549 and H1299 LUAD cell lines\",\"Cell proliferation assay\",\"Cell migration and metastasis assays\",\"Cell-cycle and p53-signaling pathway expression analysis\",\"Western blot\",\"qRT-PCR\",\"Immunohistochemistry\"],\"analysis_methods\":[\"Wilcoxon rank-sum test\",\"Signed-rank test\",\"Benjamini-Hochberg false-discovery-rate correction\",\"Kaplan-Meier survival analysis\",\"Log-rank test\",\"Univariate Cox proportional hazards regression\",\"Multivariate Cox proportional hazards regression\",\"Receiver operating characteristic curve analysis\",\"Area under the ROC curve\",\"KEGG pathway enrichment analysis\",\"Hierarchical clustering\",\"Single-cell RNA-sequencing analysis\",\"Student's t-test\",\"Two-way ANOVA\"],\"statistical_method\":\"Non-parametric Wilcoxon rank-sum tests, with signed-rank tests for paired data when useful, were used to test SSBP1 differential expression between tumor and normal tissues; the Benjamini-Hochberg approach was used to control the false discovery rate.\",\"method_evidence\":\"To assess the SSBP1 differential expression between tumor and normal tissues in different types of cancer, we used non-parametric statistical tests. These included Wilcoxon rank-sum tests to compare the levels of expression in tumor and normal tissues, and signed-rank tests to take paired data into consideration when useful. The Benjamini-Hochberg approach was used to control the false discovery rate (FDR) and further adjust statistical significance for multiple comparisons.\",\"repositories\":[{\"repository\":\"UCSC Xena database\",\"accession\":\"https://xenabrowser.net/datapages/\",\"data_description\":\"Normalized RNA-sequencing results from multiple cancer types in TCGA, together with SSBP1 expression data and clinical variables including OS, DSS, tumor stage, age, gender, treatment history, and tumor type.\",\"evidence\":\"The data for the pan-cancer expression profiles came from the UCSC Xena database, which contains normalized RNA sequencing (RNA-Seq) results from many different cancer types found in The Cancer Genome Atlas (TCGA) (https://xenabrowser.net/datapages/). For each kind of tumor that was accessible, we extracted the SSBP1 expression data and associated clinical variables, including OS, DSS, tumor stage, age, gender, treatment history, and tumor type.\",\"publicly_downloadable\":false},{\"repository\":\"The Cancer Genome Atlas\",\"accession\":\"unknown\",\"data_description\":\"Tumor and normal-tissue expression data used to compare SSBP1 expression in LUAD and other cancers; the pan-cancer analysis also used associated survival and clinical variables.\",\"evidence\":\"The data for the pan-cancer expression profiles came from the UCSC Xena database, which contains normalized RNA sequencing (RNA-Seq) results from many different cancer types found in The Cancer Genome Atlas (TCGA) (https://xenabrowser.net/datapages/).\",\"publicly_downloadable\":false},{\"repository\":\"GTEx\",\"accession\":\"unknown\",\"data_description\":\"Dataset used with TCGA and the GSE datasets to compare SSBP1 expression in LUAD tumor tissues and normal lung tissues; its exact accession and detailed contents are not stated.\",\"evidence\":\"In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.\",\"publicly_downloadable\":false},{\"repository\":\"GSE19188\",\"accession\":\"GSE19188\",\"data_description\":\"Dataset used in the LUAD expression analysis alongside TCGA, GTEx, and GSE63459; the source does not specify its detailed contents or an explicit download statement.\",\"evidence\":\"In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.\",\"publicly_downloadable\":false},{\"repository\":\"GSE63459\",\"accession\":\"GSE63459\",\"data_description\":\"Dataset used in the LUAD expression analysis alongside TCGA, GTEx, and GSE19188; the source does not specify its detailed contents or an explicit download statement.\",\"evidence\":\"In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.\",\"publicly_downloadable\":false}],\"availability_statement\":\"The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.\",\"data_on_request\":true,\"source_claims\":[\"SSBP1, a mitochondrial single-strand binding protein, was found to be significantly overexpressed in lung adenocarcinoma (LUAD) tissues, indicating its potential as a diagnostic biomarker.\",\"In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.\",\"Moreover, high SSBP1 expression was strongly associated with worse overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI), further supporting its role as a prognostic marker.\",\"Multivariate Cox regression analysis confirmed that SSBP1 remains an independent predictor of poor prognosis in LUAD patients.\",\"Functional studies showed that knockdown of SSBP1 in LUAD cell lines (A549 and H1299) led to significantly reduced proliferation and migration, coupled with downregulation of key cell cycle regulators such as CDK4 and CDK6.\",\"Additionally, SSBP1 silencing inhibited LUAD cell metastasis through the p53 signaling pathway, affecting the expression of EMT markers like N-cadherin and E-cadherin.\",\"The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.\"],\"missing_information\":[\"The supplied source does not state a numerical effect size, confidence interval, hazard ratio, or p-value for the headline LUAD overexpression result.\",\"No accession is printed for TCGA, GTEx, or UCSC Xena beyond the printed Xena URL.\",\"The text does not explicitly state that the UCSC Xena, TCGA, GTEx, GSE19188, or GSE63459 data can be downloaded without an application, embargo, or request.\",\"The individual data contents of GTEx, GSE19188, and GSE63459 are not separately specified.\",\"The paper's prognostic-analysis section discusses hepatocellular carcinoma rather than explicitly stating which survival method was applied specifically to the LUAD headline result.\"],\"evidence_spans\":[\"SSBP1, a mitochondrial single-strand binding protein, was found to be significantly overexpressed in lung adenocarcinoma (LUAD) tissues, indicating its potential as a diagnostic biomarker.\",\"In this study, comprehensive analysis using multiple datasets, including TCGA, GTEx, GSE19188, and GSE63459, consistently demonstrated that SSBP1 expression is elevated in LUAD, distinguishing tumor tissues from normal lung tissues.\",\"Moreover, high SSBP1 expression was strongly associated with worse overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI), further supporting its role as a prognostic marker.\",\"Multivariate Cox regression analysis confirmed that SSBP1 remains an independent predictor of poor prognosis in LUAD patients.\",\"To assess the SSBP1 differential expression between tumor and normal tissues in different types of cancer, we used non-parametric statistical tests. These included Wilcoxon rank-sum tests to compare the levels of expression in tumor and normal tissues, and signed-rank tests to take paired data into consideration when useful.\",\"The Benjamini-Hochberg approach was used to control the false discovery rate (FDR) and further adjust statistical significance for multiple comparisons.\",\"The data for the pan-cancer expression profiles came from the UCSC Xena database, which contains normalized RNA sequencing (RNA-Seq) results from many different cancer types found in The Cancer Genome Atlas (TCGA) (https://xenabrowser.net/datapages/).\",\"For each kind of tumor that was accessible, we extracted the SSBP1 expression data and associated clinical variables, including OS, DSS, tumor stage, age, gender, treatment history, and tumor type.\",\"Functional studies showed that knockdown of SSBP1 in LUAD cell lines (A549 and H1299) led to significantly reduced proliferation and migration, coupled with downregulation of key cell cycle regulators such as CDK4 and CDK6.\",\"The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.\"]}"}, {"provider": "minimax", "model": null, "reason": "HTTP Error 429: Too Many Requests", "raw_response": null}, {"provider": "minimax_alt", "model": null, "reason": "HTTP Error 429: Too Many Requests", "raw_response": null}]}}, {"key": "source_resolution", "status": "pending", "reason": null, "evidence": null}, {"key": "protocol_reconstruction", "status": "pending", "reason": null, "evidence": null}, {"key": "control_execution", "status": "pending", "reason": null, "evidence": null}, {"key": "control_comparison", "status": "pending", "reason": null, "evidence": null}, {"key": "publication", "status": "pending", "reason": null, "evidence": null}], "gaps": ["review.human_critique", "review.machine_critique.blocked"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "package:fb5397ae07cf3dd2365f450608b0c07375a4baf603bc91ce59bde9aaac77038e", "type": "sep_package", "label": "SEP v1 package for pmid:40993492"}], "activities": [{"id": "activity:conversion:pmid:40993492", "type": "conversion", "used": ["package:fb5397ae07cf3dd2365f450608b0c07375a4baf603bc91ce59bde9aaac77038e"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:minimax_alt", "type": "model", "label": "minimax_alt"}, {"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}], "source_run_id": "run-20261023T122449232913", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "4a0ea985-8c7b-404a-b4ac-8262608b4374", "parent_hash": "fb5397ae07cf3dd2365f450608b0c07375a4baf603bc91ce59bde9aaac77038e", "fork_of": null, "generation": 1}, "gaps": ["abstract", "asset:source:pmid:40993492 not verified", "authors", "capability", "corpus_record_absent", "execution.not_run", "method", "review.human_critique", "review.machine_critique.blocked", "step:obtain_source_data blocked on data:not_downloaded", "step:run_analysis blocked on no owned computational capability is bound to this experiment", "step:run_analysis input 'materials:the source data behind the published result in pmid:40993492' does not resolve to a declared asset", "targets"]}